JustMilk wins Pitch@Palace competition

  • February 27, 2016
JustMilk wins Pitch@Palace competition

Rebekah Scheuerle and her partner win at the competition for biotech start-ups.

We received invaluable mentors, and pharmaceutical contacts, and are thrilled to have the opportunity to pitch again, this time at St. James’s Palace.

Rebekah Scheuerle

A Gates Cambridge Scholar and her partner have won a highly selective biotechnology competition where they pitched plans to commercialise their novel device for administering life-saving drugs to infants during breastfeeding.

Rebekah Scheuerle [2013] and WD Armstrong Scholar Theresa Maier recently co-founded the non-profit JustMilk Limited to commercialise the device. At the start of March they won the Pitch@Palace Bootcamp, a competition put on by His Royal Highness the Duke of York and held for the first time in Cambridge. They then joined 13 start-ups at St. James’s Palace on 7 March for Pitch@Palace 5.0. There they pitched successfully for support, funding and partnership to an audience including venture capitalists, grant funding directors and pharmaceutical company executives and won first place overall.

The purpose of the event was to accelerate the development of start-ups through providing networking opportunities with investors, potential business partners and mentors.

"It was such a privilege to be hosted in St James' Palace by His Royal Highness the Duke of York and his team to speak about our venture. It gave us the opportunity to give a voice to the millions of infants at risk of death from preventable disease, if only they had hygienic paediatric medicines available. Speaking to such an influential audience was incredibly inspiring and an unparalleled opportunity to direct attention to the magnitude of need for innovation for paediatric medicines and their delivery systems. The audience was overwhelmingly supportive and empathetic to our cause. We are so grateful for the vast expansion of our network that has been enabled, and the ways so many people have offered help, through contacts in the pharmaceutical industry, venture capital firms, grant funding agencies and ministries of health. We look forward to the ways in which our new contacts can facilitate the implementation of the project," said Rebekah, who is doing a PhD in Chemical Engineering. 

JustMilk are now meeting with interested pharmaceutical companies, as well as investigating potential investment and grant funding opportunities that are being suggested.  They are looking to work with a pharmaceutical partner to develop the medicines that go in the device and assist with applying for regulatory approval and clinical development. The company is receiving a host of networking opportunities from the Duke of York's office to propel its development. It has also received ongoing feedback from mentors throughout the entire process.

The JustMilk project aims to prevent child mortality using a novel device worn during breastfeeding that administers compounds like antiretrovirals or nutrients into milk consumed by an infant. The device could be useful in low-resource settings because it does not require potable water for washing the device nor suspending the medicine. It doesn’t need refrigerated storage nor literacy for dose measuring. Furthermore, since it is worn during breastfeeding, JustMilk hopes to promote this nutritionally beneficial practice.  The JustMilk non-profit has focused on developing the device for these settings, having received positive feedback from mothers in rural regions of South Africa and Kenya.

The project is expanding to include applications in western markets, motivating Rebekah and Theresa to form the UK-based company, JustMilk Limited.  Thanks to the University of Cambridge Judge Business School’s Accelerate Cambridge programme, they have received extensive mentorship and support for launching the business. They are now seeking financial support to enable the first clinical investigation of the device and a pharmaceutical partner to license the technology.

Rebekah Scheuerle

Rebekah Scheuerle

  • Alumni
  • United States
  • 2013 PhD Chemical Engineering
  • St John's College

I am so honored to be pursuing my PhD in chemical engineering at Cambridge! I will be studying biopharmaceutical development and drug delivery in the lab of Dr. Nigel Slater. Although therapeutic development is necessary globally, the world is in desperate need of affordable, optimized therapies and diagnostics for resource-limited environments. Millions of people do not have access to the electricity and refrigeration required for many current medical treatments. I hope to use my experience in polymeric drug delivery from The University of Texas, microfluidic diagnostics from U.C. Berkeley, vaccine commercialization from Merck Sharp and Dohme, and antibody purification development from Genentech to support me in my graduate studies. I plan on using the skills I acquire at Cambridge in a future career developing biotechnology-based solutions to world health problems.

Previous Education

University of Texas Austin BSc Chemical Engineering 2013

Latest News

The process of history-making

Olin Moctezuma-Burns [2020] is keen not to repeat the patterns of some past researchers and to give back to the communities she studies. For that reason she recently co-organised an international gathering of Imagining Futures projects on archiving indigenous and traditional knowledges in Sotuta, Yucatan. The meeting brought together people from Colombia, Peru, Kenya, Tanzania, […]

How might extreme heat contribute to human migration?

Rising temperatures due to climate change are likely influencing human migration patterns, according to a new study co-authored by Gates Cambridge Scholar Dr Kim van Daalen [2018]. The study, led by Rita Issa of University College London, is published today in the open-access journal PLOS Climate. It looks at the role of heat in human […]

Scholar scoops prestigious science innovation fellowship

Freja Ekman has been named one of the 2023 class of Hertz Fellows as the prestigious fellowship celebrates its 60th year. The 15 fellowships in applied science, engineering and mathematics are awarded by Fannie and John Hertz Foundation, a non-profit organisation for innovators in science and technology. Winners will have their graduate studies funded for […]

Scholar hosts first UN communications technology access meeting in India

Gates Cambridge Scholar Pradipta Biswas has hosted a UN meeting on improving access to communications technology – the first ever held in India. The meeting of ITU-T Study Group 9 (SG-9) on “Broadband Cable and Television/Audiovisual content transmission and integrated broadband cable networks”  was held in May at the Indian Institute of Science in Bengaluru […]